Alveo Technologies

Alveo Technologies is a US-based startup in the healthcare industry, with a mission to detect pathogens before they spread using an open, accessible, and actionable molecular detection platform. Founded in 2014, the company has developed a portable, handheld analyzer and cloud-based data analytics to bring molecular detection out of the lab and into the field. Their agile platform can detect a wide range of pathogens including viruses, bacteria, and fungi, offering real-time data precisely when and where it matters most. Alveo's recent Series A investment in 01 May 2021 by BDV Fund reflects growing investor interest in the company's innovative approach. With the slogan "Know Sooner, Act Faster™," Alveo Technologies is poised to make a significant impact in the field of early pathogen detection.